LobbyingSumitomo Pharma America lobbying by quarter
Sumitomo Pharma America's latest lobbying report covers Q2 2026, at $60K. The four quarters Q4 2025–Q3 2026 total $100K. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid and Health Issues.
Sumitomo Pharma America
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $100K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $50K | 1 |
| Q1 2023 | $50K | 1 |
| Q2 2023 | $70K | 1 |
| Q3 2023 | $70K | 1 |
| Q4 2023 | $70K | 1 |
| Q1 2024 | $70K | 1 |
| Q2 2024 | $0 | 0 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $40K | 1 |
| Q2 2026 | $60K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Medicare and Medicaid$290K · 6 reports
- Health issues$190K · 4 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES6 reports
- SENATE6 reports
- Health & Human Services, Dept of (HHS)2 reports
- White House Office2 reports
Firms it paid
| Firm | ||
|---|---|---|
| Impact Health Policy Partners | $380K | 6 quarters |
| Arnold & Porter Kaye Scholer | $100K | 2 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/17for Q2 | Arnold & Porter Kaye Scholer | $60K |
| 04/17for Q1 | Arnold & Porter Kaye Scholer | $40K |
| 03/23for Q1 | Arnold & Porter Kaye Scholer | Under $5,000 |
| 24/04/18for Q1 2024 | Impact Health Policy Partners | $70K |
| 24/01/22for Q4 2023 | Impact Health Policy Partners | $70K |
| 23/10/20for Q3 2023 | Impact Health Policy Partners | $70K |
| 23/07/19for Q2 2023 | Impact Health Policy Partners | $70K |
| 23/04/19for Q1 2023 | Impact Health Policy Partners | $50K |
| 23/01/20for Q4 2022 | Impact Health Policy Partners | $50K |